SCHEMBL7663243

SCHEMBL7663243

COc1ccc(C(=O)Nc2ccc(/C=C/c3ccc(NC(=O)c4ccc(OC)c(S(=O)(=O)NCCN5CCOCC5)c4)cc3S(=O)(=O)O)c(S(=O)(=O)O)c2)cc1S(=O)(=O)NCCN1CCOCC1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.56
ALDH1A1 P00352 5/20 0.51
MAPK1 P28482 4/20 0.51
LMNA P02545 3/20 0.51
MAPT P10636 2/20 0.50
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
TSHR P16473 2/20 0.49
KDM4E B2RXH2 2/20 0.49
GAA P10253 2/20 0.49
HSD17B10 Q99714 2/20 0.49
CYP2D6 P10635 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 1/20 0.46
USP2 O75604 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7663344 1.00 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1MAPK1LMNAMAPT
SCHEMBL8019642 0.89 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1MAPK1LMNAMAPT
SCHEMBL7676271 0.86 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1MAPK1LMNAMAPT
SCHEMBL7668690 0.84 MAPT (0.61) SMN1; SMN2ALDH1A1MAPK1LMNAMAPT
SCHEMBL7668618 0.84 MAPT (0.61) SMN1; SMN2ALDH1A1MAPK1LMNAMAPT
SCHEMBL7666544 0.84 KMT2A (0.68) SMN1; SMN2ALDH1A1MAPK1LMNAMAPT
SCHEMBL7666465 0.84 KMT2A (0.68) SMN1; SMN2ALDH1A1MAPK1LMNAMAPT
SCHEMBL7662978 0.80 SMN1; SMN2 (0.72) SMN1; SMN2ALDH1A1MAPTKMT2AL3MBTL1
SCHEMBL15754508 0.80 SMN1; SMN2 (0.72) SMN1; SMN2ALDH1A1MAPK1MAPTKMT2A
SCHEMBL7658982 0.79 LMNA (0.64) SMN1; SMN2ALDH1A1MAPK1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020111369-A1 Aryl sulfonic acids and derivatives as FSH antagonists AMERICAN HOME PRODUCTS CORPORATION (US) 2002-08-15 US disclosed
US-6355633-B1 CONTRACEPTIVES AMERICAN HOME PRODUCTS CORPORATION 2002-03-12 US disclosed
WO-2000058277-A1 ARYL SULFONIC ACIDS AND DERIVATIVES AS FSH ANTAGONISTS AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020111369-A1 Aryl sulfonic acids and derivatives as FSH antagonists FSHR, GNRHR, LHCGR SMN1; SMN2 2927/4885ALDH1A1 3990/4885MAPK1 1934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.